Insider Stock Trading History of Gryska David W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gryska David W since year 2005. The trader's CIK number is 1202335. At the time of this reporting, Gryska David W is the Executive Vice President, CFO of Incyte Corp . (stock ticker symbol INCY). See this page for all insider trading activities at Incyte Corp .

Note that in the past GRYSKA DAVID W also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Gryska David W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-05 INCY Incyte Corp Sale 6,760 98.87 668,361
2018-01-05 INCY Incyte Corp Option Ex 6,760 83.83 566,690
2017-11-02 INCY Incyte Corp Sale 3,915 105.63 413,541
2017-06-30 INCY Incyte Corp Option Ex 599 73.21 43,852
2017-06-30 INCY Incyte Corp Sale 599 129.74 77,714
2017-06-12 INCY Incyte Corp Option Ex 16,756 73.21 1,226,706
2017-06-12 INCY Incyte Corp Sale 16,756 116.60 1,953,749
2017-04-28 INCY Incyte Corp Sale 1,389 124.26 172,597
2017-04-28 INCY Incyte Corp Option Ex 1,389 67.06 93,146
2017-04-10 INCY Incyte Corp Option Ex 41,528 67.06 2,784,867
2017-04-10 INCY Incyte Corp Sale 41,528 138.00 5,730,864
2016-09-06 SGEN Seattle Genetics Inc /wa Option Ex 10,000 10.20 102,000
2015-11-05 SGEN Seattle Genetics Inc /wa Sale 10,000 43.57 435,740
2015-04-08 SGEN Seattle Genetics Inc /wa Option Ex 5,000 8.38 41,900
2013-09-03 SGEN Seattle Genetics Inc /wa Option Ex 10,000 10.08 100,800
2013-09-03 SGEN Seattle Genetics Inc /wa Sale 10,000 42.48 424,799
2013-02-26 SGEN Seattle Genetics Inc /wa Option Ex 10,000 6.69 66,900
2013-02-25 SGEN Seattle Genetics Inc /wa Sale 10,000 27.17 271,700
2012-08-10 SGEN Seattle Genetics Inc /wa Option Ex 7,500 5.00 37,500
2012-06-05 SGEN Seattle Genetics Inc /wa Sale 8,000 19.75 158,000
2011-12-15 SGEN Seattle Genetics Inc /wa Option Ex 4,500 5.00 22,500
2011-12-09 SGEN Seattle Genetics Inc /wa Sale 10,000 18.09 180,920
2010-11-12 SGEN Seattle Genetics Inc /wa Option Ex 4,000 5.00 20,000
2010-05-04 CELG Celgene Corp /de/ Sale 5,594 60.00 335,640
2010-05-03 CELG Celgene Corp /de/ Sale 32,499 61.63 2,003,075
2010-05-04 CELG Celgene Corp /de/ Option Ex 6,458 44.69 288,575
2010-05-03 CELG Celgene Corp /de/ Option Ex 32,499 50.42 1,638,762
2010-02-17 SGEN Seattle Genetics Inc /wa Option Ex 4,000 4.18 16,720
2009-07-20 SGEN Seattle Genetics Inc /wa Option Ex 4,000 5.00 20,000
2008-11-03 CELG Celgene Corp /de/ Option Ex 23,264 57.58 1,339,541
2008-11-03 CELG Celgene Corp /de/ Sale 23,264 64.50 1,500,528
2008-01-17 SGEN Seattle Genetics Inc /wa Option Ex 6,000 4.18 25,080

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gryska David W (Executive Vice President, CFO of Incyte Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.